Literature DB >> 24480775

Osteoblastic differentiation and mineralization ability of periosteum-derived cells compared with bone marrow and calvaria-derived cells.

Juan Marcelo Rosales-Rocabado1, Masaru Kaku2, Megumi Kitami3, Yosuke Akiba4, Katsumi Uoshima5.   

Abstract

PURPOSE: Clinically, bone marrow stromal cells (BMCs) are the most common source of osteoprogenitor cells. Its harvest process, however, is invasive to patients. Previous reports have shown the potential advantages of using periosteum-derived cells (PDCs) as a source of cell-based transplant therapy. The objective of our study was to characterize the osteoblastic differentiation and mineralization ability of PDCs versus BMCs and osteoblasts (OBs).
MATERIALS AND METHODS: BMCs, OBs, and PDCs were isolated from 4-week-old male Wistar rats. To characterize the differentiation ability of the cells, MTS assay, alkaline phosphatase (ALP) activity staining, picrosirius red staining, and alizarin red staining were performed. Immunohistochemistry was performed on paraffin sections of calvarial periosteum to determine the presence of mesenchymal stem cells.
RESULTS: PDCs showed the greatest proliferation rate compared with BMCs and OBs. Matured collagenous matrix formation was observed in PDCs and BMCs. ALP-positive cells and in vitro mineralization were evident in all cell types analyzed; however, that of PDCs was not comparable to that of the OBs and BMCs. Immunohistochemistry revealed the presence of STRO-1-and CD105-positive cells in the cambium layer of the periosteum.
CONCLUSIONS: PDCs have remarkable proliferative ability, but contain only a small population of osteogenic cells compared with BMCs and OBs. Although cell activity can be affected by various factors, such as age, culture condition, additives, and so forth, PDCs are likely not the source of OBs, although they might provide matrices that indirectly aid in bone formation.
Copyright © 2014 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24480775     DOI: 10.1016/j.joms.2013.12.001

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  5 in total

1.  Cerium promotes bone marrow stromal cells migration and osteogenic differentiation via Smad1/5/8 signaling pathway.

Authors:  Ying Hu; Yi Du; Huan Jiang; Guang-Shui Jiang
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

2.  Synthesis of Ce/Gd@HA/PLGA Scaffolds Contributing to Bone Repair and MRI Enhancement.

Authors:  Xianji Song; Xilin Liu; Yihang Ma; Qingsan Zhu; Mingchao Bi
Journal:  Front Bioeng Biotechnol       Date:  2022-03-31

3.  Effects of negative pressure wound therapy on mesenchymal stem cells proliferation and osteogenic differentiation in a fibrin matrix.

Authors:  Jin Zhu; Aixi Yu; Baiwen Qi; Zonghuan Li; Xiang Hu
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

4.  Bone formation in subcutaneous pocket after bone flap preservation.

Authors:  Wen-Xue Wang; Nana Jiang; Jian-Wei Wang; Xin Kang; Guang-Hui Fu; Yu-Liang Liu
Journal:  Clin Case Rep       Date:  2016-03-29

5.  Extracellular matrix with defective collagen cross-linking affects the differentiation of bone cells.

Authors:  Takako Ida; Masaru Kaku; Megumi Kitami; Masahiko Terajima; Juan Marcelo Rosales Rocabado; Yosuke Akiba; Masako Nagasawa; Mitsuo Yamauchi; Katsumi Uoshima
Journal:  PLoS One       Date:  2018-09-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.